Erratum to: Which is the best aromatase inhibitor for postmenopausal breast cancer?

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2001年 / 17卷 / 6期
关键词：
D O I：
10.2165/00042310-200117060-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：15 / 15
相关论文
共 50 条
  • [1] Which is the best aromatase inhibitor for postmenopausal breast cancer?
    Drugs & Therapy Perspectives, 2000, 16 (8) : 5 - 7
  • [2] Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor
    Wiwanitkit, Somsri
    Wiwanitkit, Viroj
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (03): : 217 - 217
  • [3] Effect of a switch of aromatase inhibitors to another aromatase inhibitor or tamoxifen on musculoskeletal symptoms in breast cancer; Which is the best?
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (04): : 2132 - 2133
  • [4] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
    Gnant, Michael
    Fitzal, Florian
    Rinnerthaler, Gabriel
    Steger, Guenther G.
    Greil-Ressler, Sigrun
    Balic, Marija
    Heck, Dietmar
    Jakesz, Raimund
    Thaler, Josef
    Egle, Daniel
    Manfreda, Diether
    Bjelic-Radisic, Vesna
    Wieder, Ursula
    Singer, Christian F.
    Melbinger-Zeinitzer, Elisabeth
    Haslbauer, Ferdinand
    Sevelda, Paul
    Trapl, Harald
    Wette, Viktor
    Wimmer, Kerstin
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Kacerovsky-Strobl, Stephanie
    Suppan, Christoph
    Brunner, Christine
    Deutschmann, Christine
    Soelkner, Lidija
    Fesl, Christian
    Greil, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
  • [5] Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women
    Kao, YC
    Okubo, T
    Sun, XZ
    Chen, S
    ANTICANCER RESEARCH, 1999, 19 (3A) : 2049 - 2056
  • [6] Adjuvant Aromatase Inhibitor Options in Overweight and Obese Postmenopausal Women with Breast Cancer
    Chlebowski, Rowan T.
    BREAST JOURNAL, 2013, 19 (05): : 552 - 554
  • [7] Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
    Chen, Han
    Shao, Zhi-Ming
    Yu, Ke-Da
    Xu, Ge-Zhi
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [8] Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
    Buzdar, Aman U.
    Coombes, R. Charles
    Goss, Paul E.
    Winer, Eric P.
    CANCER, 2008, 112 (03) : 700 - 709
  • [9] Sexual Dysfunction in Postmenopausal Women with Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
    Lubian Lopez, Daniel Maria
    Butron Hinojo, Carmen Aisha
    Sanchez-Prieto, Manuel
    Mendoza, Nicolas
    Sanchez-Borrego, Rafael
    BREAST CARE, 2021, 16 (04) : 376 - 382
  • [10] Role function in postmenopausal women during aromatase inhibitor therapy for breast cancer
    Melnyk, Halia
    Dickson, Victoria Vaughan
    Bender, Catherine
    Yu, Gary
    Djukic, Maja
    Merriman, John
    JOURNAL OF CANCER SURVIVORSHIP, 2024,
12345